Testing effectiveness (Phase 2)Study completedNCT02215616
What this trial is testing
A Clinical Study in Participants With Huntington's Disease (HD) to Assess Efficacy and Safety of Three Oral Doses of Laquinimod
Who this might be right for
Huntington's Disease
Teva Branded Pharmaceutical Products R&D, Inc. 352